Personalis to Present at the Stifel 2024 Healthcare Conference
Personalis, a leading company in advanced genomics for precision oncology, has announced its participation in the Stifel 2024 Healthcare Conference. The company's management team is scheduled to present on Tuesday, November 19, at 10:55 a.m. Eastern Time. The presentation will take place at the Lotte New York Palace Hotel in New York, NY.
Personalis, un'azienda leader nella genomica avanzata per l'oncologia di precisone, ha annunciato la sua partecipazione alla Stifel 2024 Healthcare Conference. Il team di gestione dell'azienda è programmato per presentare martedì 19 novembre alle 10:55 ora dell'Est. La presentazione avrà luogo presso il Lotte New York Palace Hotel a New York, NY.
Personalis, una empresa líder en genómica avanzada para oncología de precisión, ha anunciado su participación en la Stifel 2024 Healthcare Conference. El equipo directivo de la compañía está programado para presentar el martes 19 de noviembre a las 10:55 a.m., hora del Este. La presentación se llevará a cabo en el Lotte New York Palace Hotel en Nueva York, NY.
Personalis, 정밀 종양학을 위한 첨단 유전체학의 선두 기업이 Stifel 2024 Healthcare Conference에 참여한다고 발표했습니다. 회사의 경영진 팀은 11월 19일 화요일 동부 표준시 기준으로 오전 10시 55분에 발표할 예정입니다. 발표는 뉴욕 NY의 Lotte New York Palace Hotel에서 진행됩니다.
Personalis, une entreprise de pointe en génomique avancée pour l'oncologie de précision, a annoncé sa participation à la Stifel 2024 Healthcare Conference. L'équipe de direction de l'entreprise doit présenter le mardi 19 novembre à 10h55, heure de l'Est. La présentation se déroulera au Lotte New York Palace Hotel à New York, NY.
Personalis, ein führendes Unternehmen in der fortschrittlichen Genomik für präzise Onkologie, hat seine Teilnahme an der Stifel 2024 Healthcare Conference angekündigt. Das Management-Team des Unternehmens wird am Dienstag, den 19. November, um 10:55 Uhr Eastern Time präsentieren. Die Präsentation findet im Lotte New York Palace Hotel in New York, NY statt.
- None.
- None.
About Personalis, Inc.
At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding care from biopsy through the life of the patient. Our highly sensitive assays combine tumor-and-normal profiling with proprietary algorithms to deliver advanced insights even as cancer evolves over time. Our products are designed to detect minimal residual disease (MRD) and recurrence at the earliest timepoints, enable the selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Personalis is based in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241105986994/en/
Investors:
Caroline Corner
investors@personalis.com
415-202-5678
Media:
pr@personalis.com
Source: Personalis, Inc.
FAQ
When is Personalis (PSNL) presenting at the Stifel 2024 Healthcare Conference?
Where will the Personalis (PSNL) Stifel 2024 Healthcare Conference presentation take place?
What type of company is Personalis (PSNL)?
Which conference is Personalis (PSNL) participating in for 2024?
